Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-01-28EMA Authorised: Erbitux (cetuximab) — Merck Europe B.V.
EMA authorised Erbitux (cetuximab) for head and neck cancer and colorectal cancer under Merck Europe B.V.
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors [Phase 1]
Phase 1 dose-finding study evaluating safety, tolerability, and pharmacokinetics of SNB-101 (SN-38) in patients with colorectal, breast, pan…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Ozone Therapy for the Treatment of Oral Mucositis in Patients Undergoing Radio and Chemotherapy in the Head and Neck Region
A completed clinical trial evaluated ozone therapy as a treatment for oral mucositis in patients undergoing radiotherapy and chemotherapy fo…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Randomized Evaluation of Machine Learning Assisted Radiation Treatment Planning vs Standard Radiation Treatment Planning [NA]
A Mayo Clinic-sponsored randomized trial evaluating machine learning-assisted radiation treatment planning versus standard planning in head …
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: DENTOFACIAL-PBT Stage 2 - Feasibility Study
Feasibility study update for DENTOFACIAL-PBT Stage 2; enrollment is ongoing by invitation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose) [Phase 2]
Phase 2 interventional Bayesian adaptive randomized-controlled platform trial to reverse external-beam radiotherapy-associated fibrosis synd…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers [EARLY_Phase 1]
An early-phase 1 trial at Brigham and Women's Hospital is screening a novel IMD drug in patients with salivary gland cancers and head and ne…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy [Phase 2]
This clinical trial update describes a Phase 2 study investigating oral herpesviruses and oral mucositis in patients undergoing head and nec…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Flexible Intubation Scope With or Without Video Laryngoscope in Supporting Endotracheal Tube Placement in Patients With Head and Neck Cancer Before Surgery [NA]
Clinical trial evaluating flexible intubation scope with or without a video laryngoscope for guiding endotracheal tube placement in patients…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating OCT-598 in patients with advanced solid tumors; the study is currently recruiting and includes multiple tu…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Diffusion MRI for Head and Neck Cancer [NA]
This clinical trial update notes a diffusion MRI study for head and neck cancer sponsored by NYU Langone Health; the study is currently acti…
-
CLINICAL_TRIALS other · 2026-01-22Clinical Trial Update: Reducing Skin Side Effects in Patients Receiving Radiation on Tomotherapy [NA]
An update on a clinical trial evaluating methods to reduce skin toxicity from Tomotherapy radiation in head and neck cancer. The study is no…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Access to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC) [NA]
Describes the ENRICH-HNC study, a trial evaluating an access-to-care program for emergency department-presenting patients with head and neck…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3 [NA]
An ongoing clinical trial comparing FDG-PET guided Dose-PAINT radiotherapy versus standard radiotherapy for primary head and neck cancer, cu…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema [NA]
A clinical trial is evaluating photobiomodulation for chronic lymphedema of the head and neck in patients with head and neck cancer. The stu…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer [Phase 2]
Phase 2 clinical trial evaluating nimotuzumab in combination with toripalimab and chemotherapy for locally advanced tonsillar cancer, a form…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery [NA]
A Wake Forest trial is evaluating postoperative radiotherapy for intermediate- and high-risk head and neck squamous cell carcinoma patients …
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Safety and Efficacy of APG-157 in Head and Neck Cancer [Phase 2]
Phase 2 clinical trial update for APG-157 in head and neck squamous cell carcinomas; current status is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Adjuvant Radiotherapy in Early Stage Oral Cancers [NA]
A clinical trial evaluating adjuvant radiotherapy for early-stage oral cancers has completed.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence
This clinical trial update describes a University of Southern California study that aims to integratively characterize head and neck carcino…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Lead-212 PSV359 Therapy for Patients With Solid Tumors [Phase 1, Phase 2]
Perspective Therapeutics reports that Lead-212 PSV359 Therapy is being studied in Phase 1/2 trials for multiple solid tumors and is currentl…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: A Comprehensive Approach to Head and Neck Cancer Prehabilitation [NA]
This clinical trial update describes a comprehensive prehabilitation approach for head and neck cancer and notes that the study is currently…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Improving Dental Care for Patients With Head and Neck Tumors [NA]
This clinical trial is currently recruiting to study improving dental care and oral health behavior in patients with head and neck cancer.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients [NA]
Recruiting for a trial of exercise and nutritional prehabilitation in head and neck cancer patients, with focus on addressing sarcopenia.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: SL-28 for Advanced Solid Tumours [Phase 1, Phase 2]
Clinical trial update for SL-28 in advanced solid tumours across multiple indications; the Phase 1/Phase 2 study is currently not yet recrui…